Zai Lab Ltd at Bank of America Merrill Lynch Health Care Conference Transcript
My name is Ying Wong and I cover U.S. Biotech, large caps mostly for B of A. Very pleased to introduce our next presenting company, Zai Lab. And let me welcome Jonathan Wang, the Head of Development and SPV of Zai Lab. With that, let me turn over the podium for Jonathan. Welcome.
Thank you very much, Ying, and thanks to Bank of America for this kind invitation to be here. So I'm very excited today to present our company, Zai Lab. I think, so first of all, we're a NASDAQ listed innovative biotech that is based in Shanghai, China, but we have offices around in U.S., as well as other parts of China. I think we're in a really once-in-a-lifetime opportunity in China in building a fully integrated company focusing on only innovative medicine. Our ultimate vision is to build a tech hitter or [true guide] of China, where for us, the core market is mainland in China, though we want to develop drugs with global standards and for global patients around the world. Specifically to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |